tradingkey.logo

Innospec Inc

IOSP
78.960USD
+0.970+1.24%
Close 12/17, 16:00ETQuotes delayed by 15 min
1.96BMarket Cap
LossP/E TTM

Innospec Inc

78.960
+0.970+1.24%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Innospec Inc

Currency: USD Updated: 2025-12-17

Key Insights

Innospec Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 4/70 in the Chemicals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 99.33.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Innospec Inc's Score

Industry at a Glance

Industry Ranking
4 / 70
Overall Ranking
56 / 4587
Industry
Chemicals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 3 analysts
Buy
Current Rating
99.333
Target Price
+32.53%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Innospec Inc Highlights

StrengthsRisks
Innospec Inc. develops, manufactures, blends, markets, and supplies a wide range of specialty chemicals to customers in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. The Company operates through three segments: Performance Chemicals, Fuel Specialties and Oilfield Services. The Company’s Performance Chemicals business creates technology-based solutions for the personal care, home care, agrochemical, construction, mining, and other industrial markets. This segment serves multinational companies, manufacturers of personal care and home care products and global mining, agricultural and building products and other industrial companies. The Company’s Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Company’s Oilfield Services business supplies drilling, completion, and production chemicals.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 108.99%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 108.99%.
Undervalued
The company’s latest PB is 1.51, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 24.51M shares, decreasing 7.42% quarter-over-quarter.
Held by Steven Cohen
Star Investor Steven Cohen holds 11.79K shares of this stock.

Financial Health

Currency: USD Updated: 2025-12-17

The current financial score of Innospec Inc is 8.41, ranking 14/70 in the Chemicals industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 441.90M, representing a year-over-year decrease of 0.34%, while its net profit experienced a year-over-year decrease of 61.38%.

Score

Industry at a Glance

Previous score
8.41
Change
0

Financials

10.00

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

9.51

Operational Efficiency

7.22

Growth Potential

6.83

Shareholder Returns

8.51

Innospec Inc's Company Valuation

Currency: USD Updated: 2025-12-17

The current valuation score of Innospec Inc is 6.12, ranking 62/70 in the Chemicals industry. Its current P/E ratio is -1674.30, which is -106.92% below the recent high of 115.93 and 0.00% above the recent low of -1674.30.

Score

Industry at a Glance

Previous score
6.12
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 4/70
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-17

The current earnings forecast score of Innospec Inc is 8.00, ranking 10/70 in the Chemicals industry. The average price target for Innospec Inc is 100.00, with a high of 105.00 and a low of 93.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
99.333
Target Price
+32.53%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

23
Total
5
Median
7
Average
Company name
Ratings
Analysts
Innospec Inc
IOSP
3
Albemarle Corp
ALB
27
Ecolab Inc
ECL
27
Eastman Chemical Co
EMN
19
Celanese Corp
CE
18
Sociedad Quimica y Minera de Chile SA
SQM
16
1
2
3
4
5

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-17

The current price momentum score of Innospec Inc is 9.34, ranking 8/70 in the Chemicals industry. Currently, the stock price is trading between the resistance level at 82.35 and the support level at 72.83, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.15
Change
0.19

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
1.055
Buy
RSI(14)
65.126
Neutral
STOCH(KDJ)(9,3,3)
84.316
Overbought
ATR(14)
1.744
High Vlolatility
CCI(14)
82.777
Neutral
Williams %R
9.902
Overbought
TRIX(12,20)
0.229
Sell
StochRSI(14)
82.716
Buy
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
78.428
Buy
MA10
77.059
Buy
MA20
75.117
Buy
MA50
74.772
Buy
MA100
78.367
Buy
MA200
83.813
Sell

Institutional Confidence

Currency: USD Updated: 2025-12-17

The current institutional shareholding score of Innospec Inc is 10.00, ranking 1/70 in the Chemicals industry. The latest institutional shareholding proportion is 98.93%, representing a quarter-over-quarter decrease of 3.84%. The largest institutional shareholder is The Vanguard, holding a total of 3.14M shares, representing 12.66% of shares outstanding, with 1.44% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
3.37M
-2.86%
The Vanguard Group, Inc.
Star Investors
3.16M
-1.49%
Allspring Global Investments, LLC
2.48M
+3.26%
Dimensional Fund Advisors, L.P.
1.17M
+0.94%
State Street Investment Management (US)
970.23K
-4.07%
Victory Capital Management Inc.
958.49K
-13.38%
First Trust Advisors L.P.
802.50K
-10.05%
Geode Capital Management, L.L.C.
719.60K
+2.05%
Royce Investment Partners
Star Investors
627.50K
-4.00%
Millennium Management LLC
350.00K
+105.39%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-17

The current risk assessment score of Innospec Inc is 8.31, ranking 12/70 in the Chemicals industry. The company's beta value is 0.89. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
8.31
Change
0
Beta vs S&P 500 index
0.89
VaR
+2.55%
240-Day Maximum Drawdown
+39.44%
240-Day Volatility
+32.79%

Return

Best Daily Return
60 days
+4.90%
120 days
+4.90%
5 years
+12.39%
Worst Daily Return
60 days
-3.11%
120 days
-3.11%
5 years
-10.27%
Sharpe Ratio
60 days
+0.06
120 days
-0.45
5 years
-0.02

Risk Assessment

Maximum Drawdown
240 days
+39.44%
3 years
+46.33%
5 years
+46.33%
Return-to-Drawdown Ratio
240 days
-0.68
3 years
-0.22
5 years
-0.11
Skewness
240 days
-0.04
3 years
+0.23
5 years
+0.24

Volatility

Realised Volatility
240 days
+32.79%
5 years
+30.47%
Standardised True Range
240 days
+3.04%
5 years
+3.30%
Downside Risk-Adjusted Return
120 days
-80.03%
240 days
-80.03%
Maximum Daily Upside Volatility
60 days
+19.67%
Maximum Daily Downside Volatility
60 days
+13.96%

Liquidity

Average Turnover Rate
60 days
+0.84%
120 days
+0.88%
5 years
--
Turnover Deviation
20 days
+33.84%
60 days
+51.16%
120 days
+59.35%

Peer Comparison

Chemicals
Innospec Inc
Innospec Inc
IOSP
8.32 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Linde PLC
Linde PLC
LIN
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ecovyst Inc
Ecovyst Inc
ECVT
8.44 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
CF Industries Holdings Inc
CF Industries Holdings Inc
CF
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cabot Corp
Cabot Corp
CBT
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ingevity Corp
Ingevity Corp
NGVT
8.24 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Innospec Inc?

The TradingKey Stock Score provides a comprehensive assessment of Innospec Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Innospec Inc’s performance and outlook.

How do we generate the financial health score of Innospec Inc?

To generate the financial health score of Innospec Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Innospec Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Innospec Inc.

How do we generate the company valuation score of Innospec Inc?

To generate the company valuation score of Innospec Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Innospec Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Innospec Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Innospec Inc.

How do we generate the earnings forecast score of Innospec Inc?

To calculate the earnings forecast score of Innospec Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Innospec Inc’s future.

How do we generate the price momentum score of Innospec Inc?

When generating the price momentum score for Innospec Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Innospec Inc’s prices. A higher score indicates a more stable short-term price trend for Innospec Inc.

How do we generate the institutional confidence score of Innospec Inc?

To generate the institutional confidence score of Innospec Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Innospec Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Innospec Inc.

How do we generate the risk management score of Innospec Inc?

To assess the risk management score of Innospec Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Innospec Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Innospec Inc.
KeyAI